• Opinion: Much Adu about nothing: New Alzheimer's drug threatens state Medicaid budgets

    12 days ago - By STAT

    A new drug that was supposed to be a lifeline for thousands of individuals and families struggling with the tragic impacts of Alzheimer's disease is evolving into a millstone around the neck of Medicaid, America's largest safety net health insurer.
    The Medicaid program, which today connects one in every four Americans to the health care they need, is an essential part of the U.S.'s health care fabric. But a recent decision by the Food and Drug Administration to approve Aduhelm , an unproven and exceptionally costly new drug to treat the symptoms of early Alzheimer's disease, could threaten...
    Read more ...